AOL Money & Finance

short sellers posts

Feed

Boston Beer blows away 3Q expectations, hikes 2009 forecast

Shares of The Boston Beer Company (NYSE: SAM) surged to a new 52-week high Friday morning, after the brewmaster reported a third-quarter profit of $10.4 million, or 72 cents per share, on revenue of $108.7 million. The company swung to a loss of 2 cents per share in the third quarter of 2008, but attributed its turnaround to strong shipments and decreased advertising expenses.

The results were better than analysts expected, with consensus estimates calling for Boston Beer to bank a profit of 39 cents per share on $107.5 million. Looking forward, Boston Beer now expects full-year earnings of $1.75 per share to $2.05 per share, a marked increased from its prior forecast for a 2009 profit of $1.40 per share to $1.70 per share.

Continue reading Boston Beer blows away 3Q expectations, hikes 2009 forecast

Lumber Liquidators rises, then falls, after solid 3Q report

Traders initially seemed thrilled with Wednesday's third-quarter earnings report from Lumber Liquidators (NYSE: LL), but the stock then backpedaled into the red. The retailer banked a quarterly profit of $7.8 million, or 28 cents per share, up from its year-ago net income of $5.5 million, or 20 cents per share. Revenue for the period surged 14% to $140.5 million. The results comfortably outpaced analysts' consensus estimates, which called for a profit of 24 cents per share on $137.1 million in revenue.

Looking ahead, Lumber Liquidators is forecasting full-year revenue of $535 million to $543 million, up from its previous guidance of $528 million to $538 million. Earnings for fiscal 2009 are expected to range between 90 cents and 95 cents per share, compared to the retailer's previous forecast of 85 cents to 91 cents per share. Wall Street, on average, is expecting full-year earnings of 90 cents per share on $537.1 million.

Continue reading Lumber Liquidators rises, then falls, after solid 3Q report

Geron Corp. spikes on narrower-than-forecast 3Q loss

Geron Corp. (NASDAQ: GERN) surged right out of the gate Friday morning, as traders cheered the stem cell stock's narrower-than-expected quarterly loss. After Thursday's close, Geron reported a third-quarter loss of $15.2 million, or 17 cents per share, while revenue arrived at $494,000.

Operating expenses for the quarter fell on a year-over-year basis from $18.3 million to $16.9 million, while research and development costs dwindled from $14.2 million to $13.4 million.

Continue reading Geron Corp. spikes on narrower-than-forecast 3Q loss

AIG recoups billions in collateral payments

A report in Thursday's The Wall Street Journal [subscription required] reveals that American International Group (NYSE: AIG) is actually reaping the benefits of its risky bets in the credit-default swap market.

AIG was forced to shell out billions to Wall Street banks amid last year's credit crisis, as the assets backed by the credit-default swaps plummeted in value. However, the market's reversal of fortune means that banking heavyweights, such as Goldman Sachs Group (NYSE: GS), are now returning collateral to the infamous insurance giant.

Continue reading AIG recoups billions in collateral payments

LDK Solar hikes revenue forecast, but stock's still struggling

LDK Solar Co., Ltd. (NYSE: LDK) was broadly higher Tuesday after boosting its top-line guidance for the third quarter. The alternative energy issue now anticipates revenue of $270 million to $290 million for the period, compared to its earlier forecast for $240 million to $270 million. Analysts' consensus expectations call for third-quarter revenue of just $249.9 million, according to Thomson Reuters.

LDK added that it now expects wafer shipments for the third quarter to range between 310 megawatts (MW) and 330 MW, up from its previous view of 260 MW to 300 MW. Simultaneously, the firm dropped its forecast for module shipments -- instead of 10 MW to 20 MW, LDK is now looking for module shipments of 5 MW to 10 MW.

Continue reading LDK Solar hikes revenue forecast, but stock's still struggling

Costco Wholesale surges after topping 4Q expectations

Wall Street is cheering the latest earnings report from Costco Wholesale Corporation (NASDAQ: COST), with the shares adding more than 3% within the first hour of trading. This morning, as Tom Johansmeyer reported, the wholesale club reported a 6% slide in fiscal fourth-quarter earnings, but the results nevertheless exceeded analysts' expectations.

In the wake of COST's report, analyst Brian Sozzi of Wall Street Strategies reiterated his Buy rating and $66 price target on the equity. "In our view, 4Q09 will go a long way in supporting a higher valuation for Costco," wrote Sozzi in a research note this morning. "The company has managed to control costs, drive traffic to its warehouses consistently throughout the economic downturn, paid $300 million in annual dividends in FY09 (payout ratio of 26.0% second to only Wal-Mart in the sector), and has catalysts on the horizon to showcase earnings power above currently modeled for consensus EPS."

Continue reading Costco Wholesale surges after topping 4Q expectations

Earnings preview: Shorts seem nervous ahead of PepsiCo's 3Q

Snacks-and-soda stalwart PepsiCo, Inc. (NYSE: PEP) is scheduled to unveil its third-quarter results before the market opens this Thursday, Oct. 8. Heading into the report, analysts are expecting PEP to bank a profit of $1.02 per share, according to Thomson Reuters, fractionally lower than its year-ago earnings of $1.06 per share.

PepsiCo has a healthy history in the earnings spotlight, having exceeded Wall Street's consensus expectations in each of the previous three quarters. Judging by recent option activity, traders are speculating on another upside surprise from the Frito-Lay firm.

Continue reading Earnings preview: Shorts seem nervous ahead of PepsiCo's 3Q

Debt-laden Hovnanian plans massive note sale to fund tender offer

Hovnanian Enterprises Inc. (NYSE: HOV) announced Monday morning that it will sell up to $775 million (WSJ subscription required) of seven-year notes in order to fund its previously reported tender offer for up to $759.3 million in debt. The struggling homebuilder also reported that $877 million of the notes were tendered by the early deadline on Friday. As a result, Hovnanian reduced the maximum amount of unsecured notes it will buy from $130 million to $100 million.

Last week, a Wall Street Journal article noted that Hovnanian is "hobbled" by its debt, even as the rest of the industry is ready to buy up land at a bargain. As of July 31, Hovnanian's net debt accounted for 109% of total capital, compared to an average of 26% for the dozen major homebuilders tracked by research firm Zelman & Associates.

Continue reading Debt-laden Hovnanian plans massive note sale to fund tender offer

Activision Blizzard booted from Conviction Buy list

Bright and early this morning, Goldman Sachs downgraded gaming guru Activision Blizzard (NASDAQ: ATVI) from Conviction Buy to Buy. In a note to clients, the brokerage firm explained that it sees greater relative potential for near-term price appreciation in other stocks. Goldman maintains a six-month price target of $16 on ATVI, implying expected upside of more than 29% from the shares' closing price on Wednesday.

ATVI is a ripe target for downgrades, if only because analysts are so lopsidedly optimistic toward the "Guitar Hero" parent. Zacks reports that the equity has attracted no fewer than 18 Strong Buy recommendations, plus two Buys -- with not a single Hold, Sell, or Strong Sell to be found.

Continue reading Activision Blizzard booted from Conviction Buy list

McDonald's dividend rises, but stock's still stagnant

Late Thursday, McDonald's (NYSE: MCD) announced a 10% increase to its cash dividend. The fast-food firm will now shell out 55 cents per share each quarter, bringing its total quarterly dividend payout to roughly $600 million. The increase will cost McDonald's about $220 million per year. This most recent dividend hike continues a long-term trend for Mickey D's, which has raised its quarterly payout every year since 1976.

In other MCD news, Bernstein initiated coverage of the stock with an "outperform" rating. The brokerage firm likes McDonald's because of its broad global footprint, with Bernstein noting that restaurants more heavily dependent on the sluggish U.S. market could struggle.

Continue reading McDonald's dividend rises, but stock's still stagnant

Rite Aid plunges after slashing full-year outlook

Rite Aid Corp. (NYSE: RAD) wallowed in the red Thursday morning, after the drugstore chain disappointed Wall Street with its second-quarter earnings and full-year guidance.

Rite Aid said its quarterly loss narrowed to $116 million, or 14 cents per share, while revenue dwindled 2.7% to $6.3 billion. Same-store sales dipped 1.1%, while gross margin contracted from 27.4% to 26.7%.

Continue reading Rite Aid plunges after slashing full-year outlook

CarMax taps 16-month high after solid 2Q earnings

CarMax Inc. (NYSE: KMX) rallied to a new 52-week high Tuesday after topping analysts' second-quarter earnings expectations. The used-car retailer reported a quarterly profit of $103 million, or 46 cents per share, while net sales jumped 13% to $2.1 billion. By contrast, analysts were expecting net income of just 18 cents per share on $1.77 billion in revenue.

"The government's CARS, or 'cash for clunkers,' program resulted in a spike in traffic in late July and August," explained CEO Tom Folliard. Same-store used-unit sales for the quarter climbed 8%, bouncing back from a 17% drop in the first quarter.

Continue reading CarMax taps 16-month high after solid 2Q earnings

BioCryst Pharma rallies after lining up three flu partners

BioCryst Pharmaceuticals (NASDAQ: BCRX) was on the move Tuesday after inking letters of intent with three partners, who will take the lead on stockpiling, marketing, and distribution efforts for the company's influenza treatment in four countries. Marketing and distribution will be contingent upon local regulatory approval, but all three partners will immediately begin discussing stockpiling opportunities with the appropriate government officials.

Moksha8 Pharmaceuticals will be BioCryst's representative in Brazil and Mexico, which together account for 75% of the Latin American pharmaceutical market. Meanwhile, NT Pharma Co. is the company's Chinese partner, and Neopharm Group is taking the reins in Israel.

Continue reading BioCryst Pharma rallies after lining up three flu partners

Smith & Wesson spikes higher on earnings surprise

Late Wednesday, Smith & Wesson Holding Corp. (NASDAQ: SWHC) stepped into the earnings spotlight to release its fiscal first-quarter results. The firearm firm raked in a profit of $12.6 million, or 21 cents per share, sharply higher from its year-ago earnings of $2.3 million, or 5 cents per share. Revenue for the period jumped 30% to $102.2 million, buoyed by a 30% increase in firearm sales and a 39% gain in non-firearm sales.

The results soared past analysts' expectations, which called for a fiscal first-quarter profit of 10 cents per share on $94.1 million in revenue. SWHC's bottom line received a boost of 5 cents per share during the recently concluded quarter from its acquisition of Universal Safety Response Inc.

Continue reading Smith & Wesson spikes higher on earnings surprise

E*Trade Financial prepares for a changing of the guard

E*Trade Financial Corp. (NASDAQ: ETFC) reported Wednesday morning that its chairman and CEO, Donald Layton, will step down at the end of the year. He will retain all of his current responsibilities through the end of 2009, by which time E*Trade hopes to have named a successor.

In a warm and fuzzy press release, Layton summed up his tenure at E*Trade: "It was an exciting but very challenging time as E*TRADE dealt successfully with the severe financial distress of the last two years. Now that our major recapitalization is complete and the online brokerage business is growing again, I have accomplished what was needed for me to end my time as CEO on schedule. I wish to thank everyone involved -- it was a great team effort."

Continue reading E*Trade Financial prepares for a changing of the guard

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA+203.5210,226.94
NASDAQ+41.622,154.06
S&P 500+23.781,093.08

Last updated: November 09, 2009: 11:51 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance